Suchen Sie nach Informationen zu Glaxo US-Zentrale? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://us.gsk.com/en-us/home/
Press releases. 11 July 2022 GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses. 01 July 2022 GSK completes acquisition of Sierra Oncology. 29 June 2022 GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community. View all Press Releases.
https://us.gsk.com/en-us/contact-us/headquarters/
Inclusion and diversity at GSK in the US Back ... United States. Tel: +1 888 825 5249. USA - Research Triangle Park. Five Moore Drive. Research Triangle Park, NC. 27709-3398. USA. Tel: +1 888 825 5249. USA - Consumer Healthcare. 184 Liberty Corner Road. Warren, NJ.
https://www.nytimes.com/2022/04/05/health/fda-glaxo-antibody-us.html
By Adeel Hassan. April 5, 2022. Federal regulators said they were suspending use of a monoclonal antibody drug known as sotrovimab to treat high-risk Covid-19 patients in the United States because ...
https://en.wikipedia.org/wiki/United_States_v._Glaxo_Group_Ltd.
glaxo group ltd., 410 u.s. 52 (1973), is a 1973 decision of the united states supreme court in which the court held that (1) when a patent is directly involved in an antitrust violation, the government may challenge the validity of the patent; and (2) ordinarily, in patent-antitrust cases, " [m]andatory selling on specified terms and compulsory …
https://en.wikipedia.org/wiki/GSK_plc
GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company according to Forbes as of 2019, after Pfizer, Novartis, Roche, Sanofi, …
https://supreme.justia.com/cases/federal/us/410/52/
Glaxo Group Ltd., 410 U.S. 52 (1973) United States v. Glaxo Group Ltd. No. 71-666. Argued November 9, 1972. Decided January 22, 1973. 410 U.S. 52. Syllabus. Appellees, Imperial Chemical Industries Ltd. and Glaxo Group Ltd., British drug companies engaged in the manufacture and sale of the fungicide griseofulvin, pooled their bulk- and dosage ...
https://www.gsk.com/en-gb/media/press-releases/update-proposed-demerger-of-the-consumer-healthcare-business-from-gsk-to-form-haleon/
For investors and media only. On 23 June 2021 at its Investor Update, GSK plc (“GSK” or the “Company”) confirmed its intention to separate its Consumer Healthcare business from the GSK Group to form Haleon plc (“Haleon”), an independent listed company. It is proposed that the separation will be effected by way of a demerger (the ...
https://unctad.org/ippcaselaw/sites/default/files/ippcaselaw/2020-12/United%20States%20v%20Glaxo%20Group%20LTD%20U.S%2052%20Supreme%20Court%201973%20%2822%20January%2C%201973%29_0.pdf
United States v Glaxo Group LTD U.S 52 Supreme Court 1973 (22 January, 1973) Prepared by UNCTAD’s Intellectual Property Unit Summary The Supreme Court of the United States found that in a suit involving illegal restraint of trade, the validity of a patent could be subject to challenge if the patent is directly involved in the anti-trust ...
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Glaxo US-Zentrale gefunden haben.
